Article Details

Bioheng Biotech Raised $80 million in Series B Financing to Advance Allogeneic Immuno-Cell ...

Retrieved on: 2021-03-24 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

Bioheng Biotech Raised $80 million in Series B Financing to Advance Allogeneic Immuno-Cell .... View article details on hiswai:

Excerpt

Founded in 1998 in Silicon Valley, USA. Bluecoach Ventures China was established in 2005 to focus on early-stage venture capital investment. It has ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up